A 38-year-old man from rural Maharashtra presents with a 2-year history of progressive skin lesions and nerve thickening. On examination, he has multiple hypopigmented macules with ill-defined borders, loss of sensation in the lesions, and palpable thickening of the ulnar and peroneal nerves. Slit-skin smear examination shows 4+ acid-fast bacilli (AFB). Lepromin test is negative. Based on the clinical and bacteriological findings, what is the most appropriate MDT regimen for this patient?

Explanation

## Classification and MDT Selection **Key Point:** The clinical presentation indicates lepromatous leprosy (LL), confirmed by high bacillary load (4+ AFB on slit-skin smear) and negative lepromin test (indicating absent cell-mediated immunity). ### Diagnostic Features of Lepromatous Leprosy - Multiple ill-defined hypopigmented macules - Symmetrical nerve involvement - High bacillary load (3+ to 6+ AFB) - Negative lepromin test - Absence of sensory loss in early stages (unlike tuberculoid forms) ### MDT Regimen for Lepromatous Leprosy | Parameter | Multibacillary (MB) Leprosy | |-----------|----------------------------| | **Duration** | 12 months | | **Rifampicin** | 600 mg monthly (supervised) | | **Dapsone** | 100 mg daily (self-administered) | | **Clofazimine** | 300 mg monthly + 50 mg daily | | **Doses required** | 12 monthly doses | **High-Yield:** Lepromatous leprosy is classified as **multibacillary (MB)** disease and requires the **3-drug regimen** (RDC) for **12 months**. **Clinical Pearl:** The negative lepromin test in this patient confirms the lepromatous end of the spectrum, where cell-mediated immunity is severely impaired. This patient requires aggressive bactericidal therapy to prevent complications such as erythema nodosum leprosum (ENL). ### Why 12 Months, Not 24? WHO guidelines (since 1998) recommend 12 months of MB-MDT. The 24-month regimen is historical and no longer recommended, as 12 months achieves adequate bacterial clearance and clinical cure with better compliance. **Mnemonic:** **RDC-MB** = Rifampicin, Dapsone, Clofazimine for Multibacillary leprosy (12 months).